Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Market
Sickle Cell Disease and Hemoglobinopathies
Location
Cambridge,
MA,
USA
Coinvestors
Alexandria Venture Investments, Arix Bioscience, Bay City Capital, Lundbeckfond Ventures, New Enterprise Associates, OrbiMed Advisors, Pfizer Strategic Investments Group, RA Capital, Rock Springs Capital